Müller, Thomas R. http://orcid.org/0000-0001-5331-5522
Buggert, Marcus http://orcid.org/0000-0003-0633-1719
Article History
Received: 24 July 2023
Revised: 27 July 2023
Accepted: 2 August 2023
First Online: 19 December 2023
Competing interests
: MB is a consultant and has received honoraria from Oxford Immunotec, MSD, BMS, Pfizer, and Mabtech. All other authors declare that they have no competing interests.